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Abstract. Metabolomic data can potentially enable accurate, non-invasive and low-
cost prediction of coronary artery disease. Regression-based analytical approaches 
however might fail to fully account for interactions between metabolites, rely on a 
priori selected input features and thus might suffer from poorer accuracy. Supervised 
machine learning methods can potentially be used in order to fully exploit the 
dimensionality and richness of the data. In this paper, we systematically implement 
and evaluate a set of supervised learning methods (L1 regression, random forest 
classifier) and compare them to traditional regression-based approaches for disease 
prediction using metabolomic data.  
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1. Introduction 
Coronary artery disease (CAD) is one of the leading causes of morbidity and mortality 
worldwide [1]. Definitive diagnosis is by coronary angiography, an invasive procedure 
that can lead to severe complications [2] or by additional often costly imaging techniques. 
Non-invasive blood testing, using circulating metabolites [3] [4], could potentially 
minimize unnecessary tests and predict CAD with higher accuracy. Previous research 
however has been mainly restricted to classical regression-based methods [5] [6] and 
potentially fails to fully exploit the dimensionality and richness of the data by accounting 
for interactions between metabolites. Supervised machine learning (ML) methods might 
be better-placed to address these challenges but have yet to be systematically evaluated 
in this context. Our aims were to a) investigate and evaluate supervised ML methods for 
CAD prediction using metabolomics data and  b) compare their accuracy with traditional 
regression-based approaches. 
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2. Background 
Metabolites are small molecules produced during metabolism or generated by microbes 
within the body [7]. Metabolites are the end-products of gene expression, a process 
closely related to protein/enzymatic reactions and therefore potentially offer a direct 
molecular reflection of the cellular milieu that leads to pathophysiological changes.  
Circulating metabolites may help predict the presence of CAD by firstly identifying 
metabolic disturbances, relevant for atherosclerosis (e.g. diabetes and insulin resistance 
[8] [9]). Additionally, since atherosclerosis occurs at the blood-vessel wall interface, 
blood metabolite measurements could plausibly directly reflect this chronic process and 
help predict CAD existence and stability. However, for selected metabolites studied to 
date, the incremental predictive utility over routine clinical assessments has been modest 
and restricted to a few candidates measured using non-scalable methods.  Recent  high-
throughput, low-cost and high-dimensional methods [4] (e.g. nuclear magnetic resonance 
spectroscopy), have re-invigorated hope for using metabolic signatures for CAD 
prediction but analyses of these complex data present new challenges before realized. 
 ML techniques are data-driven approaches designed to discover statistical 
patterns in large high-dimensional multivariate data and have been previously used for 
creating accurate risk prediction models [10]. Supervised ML methods are a set of 
techniques which aim to infer a function from a labelled training dataset which can 
predict the class of future input vectors. We evaluated penalized logistic regression and 
random forest to assess the predictive performance of metabolites on CAD in a 
contemporary cohort of patients referred to hospital for chest pain investigation or 
planned coronary angiography.  
3. Methods 
3.1. Case and exposure definitions 
We used data from the Clinical Cohorts in Coronary disease Collaboration (4C) study 
(n=3409) which recruited patients with acute or stable chest pain from four UK NHS 
hospitals [11]. Patients consented to having their EHR extracted  and provided blood 
samples. We defined presence of CAD as a >50% stenosis [12], occurring in ≥1 coronary 
arteries using data from: a) coronary angiography reports and b) EHR evidence of 
previous coronary revascularization procedures (Percutaneous Coronary Intervention, 
Coronary Artery Bypass Graft) recorded in EHR. Participants in whom CAD could not 
be ascertained were excluded. For each participant, 256 metabolites were quantified 
using an NMR technique.  Full details have been published elsewhere [4] [11].  Missing 
metabolite values were imputed and zero mean unit standardized by multiple imputation 
[13] (predictive mean matching [14]) and standardized to zero mean unit variance by first 
subtracting the means and dividing by the standard deviations. Data were randomly split 
into training and test subsets using a 3:1 ratio. 
3.3 Statistical methods 
We performed logistic regression on each of log+1-transformed metabolite values 
adjusting for known risk factors. We derived principle component factors for the 
standardized metabolite values and selected the first six for analyses as they accounted 
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for >95% of the data variability. We then performed logistic regression on each of the 
Principal Component Analysis (PCA)-derived metabolite factors, and multiple logistic 
regression including all six. Adjusted (age, sex, use of statins, hypertension) and 
unadjusted models were Bonferroni corrected (p<0.05). We performed penalized logistic 
regression using the Lasso penalty which was defined as the lowest error obtained from 
a 50-fold cross-validation. We trained a random forest classifier using Gini impurity and 
5,000 trees per ensemble. Initial cross-validation was conducted on the training set for 
both the proportion of variables used per tree as well as the maximum tree depth. A 
second cross-validation was conducted on the number of variables alone, whilst allowing 
trees to grow to their maximum depth. This removed the uncertainty of tuning a second 
parameter, and the possible increase in variance due to increased depth was considered 
well counterbalanced by using a very large number of ensemble trees. Final predictions 
were the average individual pooled predictions [13] [14] across imputed datasets and 
evaluated by calculating the percentage of correct predictions, ROC curves and AUC.  
4 Results  
We identified 1474 patients with metabolomics in whom CAD was ascertained (Table 
1). 
 
Table 1. Summary of study population 
Clinical Characteristics  Clinical 
Characteristics 
   
Men (%) 1106 (78%) Statin use (%)  447 (30%)  
Age (Years) 62.4± 11.6 Diabetes (%)  523 (35%)  
BMI (kg/m2) 29.4± 5.3 Current smoker (%)  278 (28%)  
Diagnosed hypertension (%) 1146 (77%) CAD present (%)  1037 (70%)  
4.1 Comparison of model predictiveness 
In the unadjusted models, the random forest classifier had the highest AUC and accuracy 
values and highest ROC curve (Figure 1) and both ML models outperformed PCA 
regression (Table 2). AUC, raw accuracy and PPV were mostly similar across models. 
All models had significantly higher sensitivities than specificities, but PCA regression 
had the most extreme values as it predicted the vast majority of positive CAD cases 
correctly but nearly none of the negative CAD cases. The large disparity in sensitivity 
and specificity for the two other two models shows that they failed to accurately 
distinguish between disease states. When adjusting for confounders, PCA regression had 
the best accuracy but higher AUC and accuracy values compared to unadjusted models 
were observed in all models.  
 
Table 2. Adjusted/unadjusted prediction results; highest AUC values highlighted. 
Model Accuracy AUC Sensitivity Specificity PPV NPV 
PCA regression 0.686 0.625 0.984 0.026 0.691 0.429 
PCA regression adjusted 0.759 0.767 0.957 0.322 0.757 0.771 
L1 regression 0.688 0.663 0.882 0.261 0.725 0.550 
L1 regression adjusted 0.767 0.765 0.949 0.339 0.760 0.750 
Random forest 0.713 0.675 0.941 0.209 0.724 0.615 
Random forest adjusted 0.732 0.711 0.937 0.278 0.741 0.667 
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Figure 1. Unadjusted (left) and adjusted (right) ROC curve  
4.2 Model compositions and predictive metabolites 
Logistic regression: In individual metabolites, strong CAD associations after 
Bonferroni correction were primarily related to lipids, (e.g.  HDL and VLDL), 
apolipoprotein A-I, the ratio of triglycerides to phosphoglycerides and the ratio of 
omega-6, monosaturated, polysaturated values to total fatty acids.  With logistic 
regression on individual PCA-derived factors, the first PCA factor  (VLDL, ratio of 
apolipoprotein B to apolipoprotein A-I, ratio of apolipoprotein B to apolipoprotein A-I, 
0.404 variance) remained statistically significant. When using all factors and adjusting 
for confounders, the first and second factors (IDL and LDL, 0.165 variance) were 
statistically significant. 
 Penalized logistic regression: In the unadjusted models, the ratio of 
apolipoprotein B to apolipoprotein A-I was found to have the largest, statistically 
significant negative association with presence of CAD. This was followed by cholesterol 
esters in small LDL which had a large positive association with presence of CAD. 
Saturated fatty acids also had a large negative association, whilst phospholipids in 
chylomicrons and extremely large VLDL had a large positive association. Overall ~70 
predictive metabolites where included in each model with 117 metabolites included in at 
least one of the models used to average the prediction. This suggests that whilst excluding 
confounders, it is difficult to select a small profile of metabolites to accurately predict 
the presence of absence of CAD using penalized regression.  When adjusting for 
confounders, substantially fewer metabolites were selected; the ratio of monounsaturated 
fatty acids to total fatty acids and triglycerides to total lipids ratio in IDL had the largest 
statistically significant positive association while glutamine and acetoacetate had 
negative associations. 
 Random forest: In the unadjusted classifier, creatinine was the most strongly 
significant metabolite followed by triglycerides to total lipids ratio in IDL, 
phenylalanine, albumin and lactate. Similar predictors were observed in the adjusted 
models with age being the most significant component followed by creatinine, 
triglycerides to total lipids ratio in IDL, phenylalanine, albumin and lactate. Similar 
metabolite profiles for adjusted/unadjusted models suggest that random forest does not 
incorporate the additional information of confounding variables as well as the other 
models. 
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5 Concluding discussion 
While ML approaches predicted presence/absence of CAD in the unadjusted models 
(using metabolite data only) with high accuracy/sensitivity, when adjusting for 
confounders they were outperformed by PCA regression in terms of ROC AUC and 
accuracy suggesting that a small number of metabolites can potentially be included in 
prediction models. Multiple individual metabolites that were found statistically 
significant are in agreement with previous literature and our pathological understanding 
of CAD and its development. Among these, the atherogenic lipid particles such as LDL 
are known to be causally related to atherosclerosis, while others such as creatinine reflect 
renal function and are also established markers of CAD risk. Several other metabolites 
have no previous robust association with CAD including phenylalanine and lactate and 
represent potentially novel avenues for investigation. However in seeking a metabolic 
signature to predict CAD, ML models suffered from low specificity. 
This exploratory analysis has identified and exemplified the value of ML 
models for CAD prediction using high-dimensional data, and shown that accuracy of 
traditional regression-based approaches can be surpassed. Nonetheless further research 
is required before these methods can be translated into clinical solutions. 
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